Prostate cancer: Assessment of risk using digital rectal examination, tumor grade, prostate-specific antigen, and systematic biopsy

Radiologic Clinics of North America

Volumn 38, Issue 1, 2000, Pages 49-58

  Presti Jr , Joseph C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER GRADING; CANCER STAGING; DISEASE CLASSIFICATION; FINGER; HUMAN; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RECTUM; REVIEW; RISK ASSESSMENT; TUMOR VOLUME;

EID: 0033978687     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0033-8389(05)70149-4     Document Type: Review

References (45)

1. G.L. Andriole D.E. Coplen D.J. Mikkelsen Sonographic and pathological staging of patients with clinically localized prostate cancer J Urol 142 1989 1259
2. M.C. Benson I.S. Whang A. Pantuck Prostate-specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer J Urol 147 1992 815
3. S. Borirakchanyavat V. Bhargava K. Shinohara Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy Urology 50 1997 373
4. M.K. Brawer E.A.G. Aramburu G.L. Chen The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma J Urol 150 1993 369
5. W.J. Catalona A.W. Partin K.M. Slawin Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial JAMA 279 1998 1542
6. W.J. Catalona J.P. Richie J.B. deKernion Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: Receiver operating characteristic curves J Urol 152 1994 2031
7. J.J. Chang K. Shinohara V. Bhargava Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection J Urol 160 1998 2111
8. J.J. Chang K. Shinohara R.M. Hovey Prospective evaluation of systematic sextant transition zone biopsies in large prostates for cancer detection Urology 52 1998 889
9. S.M. Cohen L.B. Ellwein Cell proliferation in carcinogenesis Science 249 1990 1007
10. M.R. Cupp D.G. Bostwick R.P. Myers The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis J Urol 153 1995 1543
11. A.V. D'Amico R. Whittington S.B. Malkowicz Combined modality staging of prostate carcinoma and its utility in predicting pathologic stage and postoperative prostate specific antigen failure Urology 49 1997 23
12. A.V. D'Amico R. Whittington D. Schultz Outcome based staging for clinically localized adenocarcinoma of the prostate J Urol 158 1997 1422
13. D.D. Dietrick J.E. McNeal T.A. Stamey Core cancer length in ultrasound-guided systematic sextant biopsies: A preoperative evaluation of prostate cancer volume Urology 45 1995 987
14. L. Egevad M. Norberg S. Mattson Estimation of prostate cancer volume by multiple core biopsies before radical prostatectomy Urology 52 1998 653
15. J.I. Epstein Prediction of progression following radical prostatectomy: A multivariate analysis of 721 men with long-term follow-up Am J Surg Pathol 20 1996 286
16. L.A. Eskew R.L. Bare D.L. McCullough Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate J Urol 157 1997 199
17. D.F. Gleason G.T. Mellinger The Veterans Administration Cooperative Urological Research Group Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging J Urol 111 1974 58
18. Y. Goto M. Ohori A. Arakawa Distinguishing clinically important from unimportant prostate cancers before treatment: Value of systematic biopsies J Urol 156 1996 1059
19. P. Hammerer H. Huland A. Sparenberg Digital rectal examination, imaging, and systematic sextant biopsy in identifying operable lymph node-negative prostatic carcinoma Eur Urol 22 1992 281
20. K.K. Hodge J.E. McNeal M.K. Terris Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate J Urol 142 1989 71
21. H. Huland P. Hammerer R.P. Henke Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal examination, prostate specific antigen and the results of 6 systematic biopsies J Urol 155 1996 1344
22. H.J. Jewett The present status of radical prostatectomy for stages A and B prostatic cancer Urol Clin North Am 2 1975 105
23. J.E. McNeal Cancer volume and site of origin of adenocarcinoma in the prostate: Relationship to local and distant spread Hum Pathol 23 1992 258
24. J.E. McNeal A.A. Villers E.A. Redwine Histologic differentiation, cancer volume and pelvic lymph node metastasis in adenocarcinoma of the prostate Cancer 66 1990 1225
25. J. Pannek H.G. Rittenhouse D.W. Chan The use of percent free prostate specific antigen for staging clinically localized prostate cancer J Urol 159 1998 1238
26. J. Pannek E.N.P. Subong K. Jones The role of free/total prostate-specific antigen ratio in the prediction of final pathological stage for men with clinically localized prostate cancer Urology 48 1996 51
27. A.W. Partin B. Carter D.W. Chan Prostate specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia J Urol 143 1990 747
28. A.W. Partin M.W. Kattan E.N. Subong Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer JAMA 277 1997 1445
29. A.W. Partin J.K. Yoo H.B. Carter The use of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 150 1993 110
30. D.F. Paulson The impact of radical prostatectomy in the management of clinically localized disease J Urol 152 1994 1826
31. P.A. Peller D.C. Young D.P. Marmaduke Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens Cancer 75 1995 530
32. S.D. Perrapato G.G. Carothers T.J. Maatman Comparing clinical staging plus transrectal ultrasound with surgical-pathological staging of prostate cancer Urology 33 1989 103
33. J.C. Presti Jr R. Hovey V. Bhargava Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of carcinoma of the prostate: ethnic variations J Urol 157 1997 907
34. J.C. Presti Jr K. Shinohara P. Bacchetti The positive fraction of systematic biopsies predicts risk of relapse following radical prostatectomy Urology 52 1998 1079
35. V. Ravery L.A. Boccon-Gibod M.C. Dauge-Geffroy Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy Urology 44 1994 371
36. P.T. Scardino K. Shinohara T.M. Wheeler Staging of prostate cancer: Value of ultrasonography Urol Clin North Am 16 1989 713
37. E. Seaman M. Whang C.A. Olsson PSA Density (PSAD): Role in patient evaluation and management Urol Clin North Am 20 1993 653
38. K. Shinohara J.S. Wolf Jr P. Narayan Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications J Urol 152 1994 120
39. T.A. Stamey J.N. Kabalin J.E. McNeal Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients J Urol 141 1989 1076
40. T.A. Stamey N. Yang A.R. Hay Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 1987 909
41. M.K. Terris J.E. McNeal T.A. Stamey Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies J Urol 148 1992 829
42. V.E. Weldon F.R. Tavel H. Neuwirth Failure of focal prostate cancer on biopsy to predict focal prostate cancer: The importance of prevalence J Urol 154 1995 1074
43. W.F. Whitmore Jr Hormone therapy in prostate cancer Am J Med 21 1956 697
44. H. Zincke J.E. Oesterling M.L. Blute Long term (15 year) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer J Urol 152 1994 1850
45. A.R. Zlotta D.M. Petein M. Susani Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng/mL J Urol 160 1998 2089